300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
eSports
Biotechnology
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Theatre
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Agency for Science, Technology and Research, VC Fund

Agency for Science, Technology and Research

VC Fund

Singapore, Singapore

Agency for Science, Technology and Research is a VC fund in Singapore focused on Biotechnology and Coffee. The Agency for Science, Technology and Research (A*STAR) is the lead agency for fostering world-class scientific research and talent for a vibrant knowledge-based and innovation-driven Singapore. A*STAR oversees 18 biomedical sciences and physical sciences and engineering research entities, located in Biopolis and Fusionopolis as well as theirimmediate vicinity.A*STAR supports Singapore's key economic clusters by providing intellectual, human and industrial capital to its partners in industry. It also supports extramural research in the universities, hospitals, research centres, and with other local and international partners.

Total investments:
4
Last investment:
Lead investor:
0%

Last updated:

Industries Agency for Science, Technology and Research invests in

BiotechnologyCoffeeGoogleMedicalBig Data

Stages Agency for Science, Technology and Research invests in

Series ASeedSeries B

Countries Agency for Science, Technology and Research invests in

Singapore

Round sizes

Series A $13M–$27M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$13M–$27M

Investment Focus

Industry

  • Biotechnology 2 (50%)
  • Coffee 1 (25%)
  • Google 1 (25%)
  • Medical 1 (25%)
  • Big Data 1 (25%)
See all 14 industries →

Stage

  • Series A 2 (50%)
  • Seed 1 (25%)
  • Series B 1 (25%)

Team

NameTitleInvestmentsLinksEmail
Scientist Total investments: 0 Find email
Jia Cheong
Jia Cheong Scientist
Scientist Total investments: 0
Find email
Joshua Au
Joshua Au Head, Data Centre
Head, Data Centre Total investments: 0
Find email
Wieslaw Nowinski
Wieslaw Nowinski Director/Principal Scientist
Director/Principal Scientist Total investments: 0
Find email
Frederick Chew
Frederick Chew Chief Executive Officer
Chief Executive Officer Total investments: 0 Find email
See all 6 team members →

Investments

CompanyDescriptionRoundLinks
Prefer Prefer
Prefer is a coffee manufacturing company that is bean-free. The company uses fermentation to create coffee from waste. The fermentation process converts upcycled food by-products, from beer, bread, and tofu manufacturing, into these same aroma molecules. $2M / Seed / Feb 22, 2024
Nalagenetics Nalagenetics
Nalagenetics is a health-tech company that provides genetic testing. In 2016, the company collaborated with the Indonesian health ministry to distribute 1,000 genetic test kits in five villages in Papua and West Papua. The company's tests revealed that 20% of leprosy patients in the area carry the gene responsible for potentially fatalreactions to Dapsone, an anti-leprosy medication; this discovery assisted doctors in determining which patients could be safely treated with the antibiotic. $12.6M / Series A / Mar 25, 2022
Sentient.io Sentient.io
Sentient.io AI models, microservices, and datasets are readily available through APIs on the Sentient AI & Data Cloud Platform for easy discovery. They utilize curated public and private datasets and pre-trained and industry-proven models. The company provides unique benefits to software developers looking to create AI-enabled applications orAI-driven services by embedding AI capabilities into their applications and for enterprises by making scalability a core and enabling easy extension to existing applications. Series B / Oct 27, 2021
AUM Biosciences AUM Biosciences
AUM Biosciences is an oncology-focused biotechnology company that aims to accelerate the development of innovative, affordable medicines for patients in Asia and around the world. AUM Biosciences focuses on early-stage development of innovative medicines for the treatment of Asian-prevalent cancers. $27M / Series A / Oct 12, 2021

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Film
Cryptocurrency
SaaS
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Hospitality
Sports
Legal
eSports
Biotechnology
Construction
Consumer
Software
Renewable Energy
Crowdfunding
Venture Capital
Fashion
Social
Beauty
Infrastructure
Theatre
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Medical
Recruiting
Web3
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Agency for Science, Technology and Research invest in?

Agency for Science, Technology and Research invests primarily in Biotechnology, Coffee and Google startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Agency for Science, Technology and Research's check size?

Agency for Science, Technology and Research typically joins rounds of $13M–$27M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Agency for Science, Technology and Research participates in.

How do I contact Agency for Science, Technology and Research?

Public channels for Agency for Science, Technology and Research include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Agency for Science, Technology and Research?

The team at Agency for Science, Technology and Research includes Anbanandam Parthiban (Scientist), Jia Cheong (Scientist) and Joshua Au (Head, Data Centre), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Agency for Science, Technology and Research Agency for Science, Technology and Research Find emails